Guidance on regulatory requirements in the context of the COVID-19 pandemic

23. April 2020 – The European Commission, EMA and the European medicines regulatory network have developed a Q&A document to provide guidance to stakeholders on adaptations to the regulatory framework to address challenges arising from the COVID-19 pandemic. For further information, see: here.